Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Terminated 1Suspended 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 2

Conditions

Stomach Neoplasms 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma 1

Interventions

Paclitaxel 581Carboplatin 528Cisplatin 359Bevacizumab 256pembrolizumab 228Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 128Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 91niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 74Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 57Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Infusions, Parenteral × Gynecologic × Clear all
NCT03959761 2025-12-19

ICONIC

Hospices Civils de Lyon

Phase 1/2 Completed
22 enrolled
Gynecologic

Ovarian Neoplasms

NCT00889733 2024-03-26

OVHM-01

University Health Network, Toronto

Phase 1/2 Terminated
9 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT01342653 2016-11-21

HIPEC

Hospital General Universitario Gregorio Marañon

Phase 2 Suspended
50 enrolled
GastrointestinalGynecologic

Carcinoma, Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡